Metropolitan Life Insurance CO Axsome Therapeutics, Inc. Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$69.39 - $97.64 $6,453 - $9,080	-93 Reduced 4.55%	1,949 $155,000
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $18,282 - $21,703	264 Added 14.85%	2,042 $142,000
Q1 2023 May 15, 2023	SELL	$58.39 - $75.0 $11,853 - $15,225	-203 Reduced 10.25%	1,778 $109,000
Q4 2022 Jun 14, 2023	BUY	$39.94 - $79.72 $8,107 - $16,183	203 Added 11.42%	1,981 $153 Million
Q4 2022 Mar 30, 2023	BUY	$39.94 - $79.72 $10,304 - $20,567	258 Added 14.97%	1,981 $152,000
Q4 2022 Feb 15, 2023	BUY	$39.94 - $79.72 $10,304 - $20,567	258 Added 14.97%	1,981 $152,000
Q3 2022 Jun 14, 2023	SELL	$36.06 - $69.85 $1,983 - $3,841	-55 Reduced 3.09%	1,723 $76.9 Million
Q3 2022 Mar 30, 2023	SELL	$36.06 - $69.85 $6,707 - $12,992	-186 Reduced 9.74%	1,723 $76,000
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $6,707 - $12,992	-186 Reduced 9.74%	1,723 $77,000
Q2 2022 Jun 20, 2023	BUY	$21.74 - $46.75 $2,847 - $6,124	131 Added 7.37%	1,909 $73,000
Q1 2022 Jun 20, 2023	BUY	$23.7 - $41.39 $3,104 - $5,422	131 Added 7.37%	1,909 $79,000
Q1 2022 Mar 30, 2023	SELL	$23.7 - $41.39 $152,604 - $266,510	-6,439 Reduced 77.13%	1,909 $79,000
Q1 2022 May 12, 2022	SELL	$23.7 - $41.39 $152,604 - $266,510	-6,439 Reduced 77.13%	1,909 $79,000
Q4 2021 Jun 21, 2023	BUY	$30.7 - $43.36 $201,699 - $284,875	6,570 Added 369.52%	8,348 $315,000
Q3 2021 Jun 21, 2023	BUY	$19.91 - $68.26 $130,808 - $448,468	6,570 Added 369.52%	8,348 $275,000
Q2 2021 Jun 21, 2023	BUY	$50.63 - $73.5 $332,639 - $482,895	6,570 Added 369.52%	8,348 $563,000
Q2 2021 Mar 30, 2023	BUY	$50.63 - $73.5 $17,517 - $25,431	346 Added 4.32%	8,348 $563,000
Q2 2021 Aug 16, 2021	BUY	$50.63 - $73.5 $422,254 - $612,990	8,340 Added 104250.0%	8,348 $563,000
Q1 2021 Jun 26, 2023	BUY	$55.91 - $81.44 $347,983 - $506,882	6,224 Added 350.06%	8,002 $453 Million
Q1 2021 Mar 30, 2023	SELL	$55.91 - $81.44 $12,467 - $18,161	-223 Reduced 2.71%	8,002 $453,000
Q1 2021 May 14, 2021	SELL	$55.91 - $81.44 $459,412 - $669,192	-8,217 Reduced 99.9%	8 $453,000
Q4 2020 Jun 22, 2023	BUY	$66.31 - $86.52 $427,500 - $557,794	6,447 Added 362.6%	8,225 $670,000
Q3 2020 Jun 26, 2023	BUY	$68.34 - $85.84 $440,587 - $553,410	6,447 Added 362.6%	8,225 $586,000
Q2 2020 Jun 26, 2023	BUY	$49.87 - $98.69 $321,511 - $636,254	6,447 Added 362.6%	8,225 $676,000
Q1 2020 Jul 12, 2023	BUY	$41.2 - $101.31 $265,616 - $653,145	6,447 Added 362.6%	8,225 $483,000
Q1 2020 Mar 30, 2023	BUY	$41.2 - $101.31 $24,637 - $60,583	598 Added 7.84%	8,225 $483,000
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $24,637 - $60,583	598 Added 7.84%	8,225 $484,000
Q4 2019 Jul 12, 2023	BUY	$16.71 - $106.24 $97,736 - $621,397	5,849 Added 328.97%	7,627 $788,000
Q4 2019 Mar 30, 2023	SELL	$16.71 - $106.24 $13,969 - $88,816	-836 Reduced 9.88%	7,627 $788,000
Q4 2019 Feb 14, 2020	SELL	$16.71 - $106.24 $13,969 - $88,816	-836 Reduced 9.88%	7,627 $788,000
Q3 2019 Jul 12, 2023	BUY	$20.24 - $29.16 $135,304 - $194,934	6,685 Added 375.98%	8,463 $171,000
Q3 2019 Mar 30, 2023	BUY	$20.24 - $29.16 $131,195 - $189,015	6,482 Added 327.21%	8,463 $171,000
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $171,291 - $246,781	8,463 New	8,463 $171,000
Q2 2019 Jul 12, 2023	BUY	$13.46 - $25.75 $915 - $1,751	68 Added 3.82%	1,846 $47.5 Million

Others Institutions Holding AXSM

# of Institutions

325

Shares Held

37.7M

Call Options Held

912K

Put Options Held

855K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.89B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account